Abstract
The ingestion of Escherichia coli by human granulocytes in vitro was reduced in the presence of Bacteroides fragilis or Staphylococcus aureus. This reduction of ingestion proved to be mainly attributable to the absence of opsonization of E. coli, which was due to complement consumption by B. fragilis and S. aureus. The intracellular killing of E. coli was decreased in the presence of B. fragilis and S. aureus because of consumption of complement components required for extracellular stimulation of granulocytes to kill intracellular bacteria. Decreased intracellular killing of E. coli by granulocytes containing either B. fragilis or S. aureus is due to the limited killing capacity of granulocytes. These interactions between E. coli and B. fragilis or S. aureus found for phagocytosis and intracellular killing were also observed in in vivo studies: in an experimental thigh lesion infection in mice, E. coli showed stronger proliferation after coinoculation with B. fragilis or with S. aureus than after injection of E. coli alone. These in vitro and in vivo findings indicate that bacterial interactions, not only between aerobic and anaerobic bacteria but also between two species of aerobic microorganisms, compete for host defense mechanisms (i.e., opsonization, phagocytosis, and intracellular killing).
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Daha M. R., Van Es L. A. Enhanced alternative complement pathway-dependent degradation of soluble immunoglobulin aggregates by macrophages. Immunology. 1981 Jul;43(3):513–518. [PMC free article] [PubMed] [Google Scholar]
- Dalhoff A. Influence of Escherichia coli on Streptococcus faecalis in mixed cultures and experimental animal infections. Eur J Clin Microbiol. 1982 Feb;1(1):17–21. doi: 10.1007/BF02014135. [DOI] [PubMed] [Google Scholar]
- Dijkmans B. A., Mattie H., Hermans J., van Furth R. Quantification of the effect of anti-anaerobic drugs in experimental Bacteroides fragilis infection in mice. J Antimicrob Chemother. 1984 Jan;13(1):79–86. doi: 10.1093/jac/13.1.79. [DOI] [PubMed] [Google Scholar]
- Gorbach S. L., Bartlett J. G. Anaerobic infections. 1. N Engl J Med. 1974 May 23;290(21):1177–1184. doi: 10.1056/NEJM197405232902106. [DOI] [PubMed] [Google Scholar]
- Ingham H. R., Sisson P. R., Tharagonnet D., Selkon J. B., Codd A. A. Inhibition of phagocytosis in vitro by obligate anaerobes. Lancet. 1977 Dec 17;2(8051):1252–1254. doi: 10.1016/s0140-6736(77)92662-9. [DOI] [PubMed] [Google Scholar]
- Jones G. R. Bacterial synergy in mixed aerobic/anaerobic infections. Lancet. 1980 Apr 12;1(8172):829–829. doi: 10.1016/s0140-6736(80)91336-7. [DOI] [PubMed] [Google Scholar]
- Leijh P. C., van den Barselaar M. T., Dubbeldeman-Rempt I., van Furth R. Kinetics of intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Eur J Immunol. 1980 Oct;10(10):750–757. doi: 10.1002/eji.1830101005. [DOI] [PubMed] [Google Scholar]
- Leijh P. C., van den Barselaar M. T., van Zwet T. L., Daha M. R., van Furth R. Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes. J Clin Invest. 1979 Apr;63(4):772–784. doi: 10.1172/JCI109362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Leijh P. C., van den Barselaar M. T., van Zwet T. L., Dubbeldeman-Rempt I., van Furth R. Kinetics of phagocytosis of Staphylococcus aureus and Escherichia coli by human granulocytes. Immunology. 1979 Jun;37(2):453–465. [PMC free article] [PubMed] [Google Scholar]
- Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
- McGowan K., Gorbach S. L. Anaerobes in mixed infections. J Infect Dis. 1981 Aug;144(2):181–186. doi: 10.1093/infdis/144.2.181. [DOI] [PubMed] [Google Scholar]
- Musher D. M., McKenzie S. O. Infections due to Staphylococcus aureus. Medicine (Baltimore) 1977 Sep;56(5):383–409. doi: 10.1097/00005792-197709000-00002. [DOI] [PubMed] [Google Scholar]
- Namavar F., Verweij A. M., Bal M., van Steenbergen T. J., de Graaff J., MacLaren D. M. Effect of anaerobic bacteria on killing of Proteus mirabilis by human polymorphonuclear leukocytes. Infect Immun. 1983 Jun;40(3):930–935. doi: 10.1128/iai.40.3.930-935.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Onderdonk A. B., Kasper D. L., Mansheim B. J., Louie T. J., Gorbach S. L., Bartlett J. G. Experimental animal models for anaerobic infections. Rev Infect Dis. 1979 Mar-Apr;1(2):291–301. doi: 10.1093/clinids/1.2.291. [DOI] [PubMed] [Google Scholar]
- Reid J. H., Patrick S. Phagocytic and serum killing of capsulate and non-capsulate Bacteroides fragilis. J Med Microbiol. 1984 Jun;17(3):247–257. doi: 10.1099/00222615-17-3-247. [DOI] [PubMed] [Google Scholar]
- Reznikov M., Finlay-Jones J. J., McDonald P. J. Effect of Bacteroides fragilis on the peritoneal clearance of Escherichia coli in mice. Infect Immun. 1981 Apr;32(1):398–399. doi: 10.1128/iai.32.1.398-399.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SELBIE F. R., SIMON R. D. Virulence to mice of Staphylococcus pyogenes: its measurement and its relation to certain in vitro properties. Br J Exp Pathol. 1952 Aug;33(4):315–326. [PMC free article] [PubMed] [Google Scholar]
- Wade B. H., Kasper D. L., Mandell G. L. Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria. J Antimicrob Chemother. 1983 Oct;12 (Suppl 100):51–62. doi: 10.1093/jac/12.suppl_c.51. [DOI] [PubMed] [Google Scholar]
- van den Broek P. J., Dehue F. A., Leijh P. C., van den Barselaar M. T., van Furth R. The use of lysostaphin in in vitro assays of phagocyte function: adherence to and penetration into granulocytes. Scand J Immunol. 1981 May;15(5):467–473. doi: 10.1111/j.1365-3083.1982.tb00672.x. [DOI] [PubMed] [Google Scholar]